<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                                                          RESEARCH ARTICLE <br />  <br />  <br />                                                           Targeting Ergosterol Biosynthesis                                                           Leishmania donovani: Essentiality Sterol <br />                                                           14alpha-demethylase <br />   <br />  <br />  <br />  <br />  <br />     OPEN ACCESS                                           Abstract <br /> Citation: McCall L  El Aroussi  Choi JY, Vieira DF, <br />                                                           Leishmania protozoan parasites (Trypanosomatidae family) causative agents cu- Muylder G, Johnston JB, et al. (2015) Targeting <br /> Ergosterol Biosynthesis Leishmania donovani:           taneous, mucocutaneous visceral leishmaniasis worldwide. diseases Essentiality Sterol 14alpha-demethylase. PLoS          associated significant morbidity mortality, adequate treatments avail- <br /> Negl Trop Dis 9(3): e0003588. doi:10.1371/journal.        able. Sterol 14alpha-demethylase (CYP51) parasite sterol biosynthesis pathway pntd.0003588 <br />                                                           focus considerable novel drug target Leishmania.  Editor: Alain Debrabant, United States Food           essentiality Leishmania donovani determined.  use dual biologi- <br /> Drug Administration, UNITED STATES <br />                                                           cal pharmacological approach demonstrate CYP51 indispensable L. dono- <br /> Received: December 10, 2014                               vani. facilitated knockout approach chromosomal CYP51 genes Accepted: February 3, 2015                                knocked presence episomal complementation episome <br /> Published: March 13, 2015                                 lost parasite negative selection. addition, treated wild- <br />                                                           type L. donovani CYP51-deficient strains 4-aminopyridyl-based inhibitors  <br /> Copyright: &#194;&#169; 2015 McCall et al. open <br /> access article distributed terms         signed specifically Trypanosoma cruzi CYP51. potency lower T. cruzi, <br /> Creative Commons Attribution License, permits       inhibitors increased efficacy parasites lacking CYP51 allele compared unrestricted use, distribution, reproduction   complemented parasites, indicating inhibition parasite growth CYP51-specific <br /> medium, provided original author source credited. <br />                                                           mechanism confirming essentiality CYP51 L. donovani. Overall, results pro- <br />                                                           vide support development CYP51 inhibitors treatment D <br />                                                           visceral leishmaniasis. <br />  <br />  <br /> gov/) European Union Seventh                     Visceral leishmaniasis second lethal parasitic infection malaria. Framework Programme (602773-KINDRED JHM,                 forms leishmaniasis cause significant morbidity.  treatments <br /> http://cordis.europa.eu/fp7/home_en.html).              available, cause severe effects associated development funders role study design, data collection <br />  <br />  <br />  <br />  <br />                                                                                                               Essentiality Leishmania donovani CYP51 <br />  <br />  <br />  analysis, decision publish, preparation manuscript.                                          resistance. key difference mammalian cells Leishmania parasites type <br /> Competing Interests: authors declared           sterol membranes: mammalian cell membranes contain <span id='am-110' about='obo:IMR_0200486' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-111' property="oboInOwl:hasDbXref" content="KEGG:C00187" datatype="xsd:string"></span><span id='am-112' property="oboInOwl:id" content="IMR:0200486" datatype="xsd:string"></span><span id='am-113' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-114' property="rdfs:label" content="Cholesterol" datatype="xsd:string"></span>cholesterol</span>, Leish- competing interests exist.                       mania parasites use ergosterol. considerable develop- <br />                                                          ing inhibitors sterol biosynthesis pathways target Leishmania parasites. Sterol <br />                                                          14alpha-demethylase (CYP51) enzymes sterol biosynthesis pathway, <br />                                                          target significant drug development research Leishmania. use dou- <br />                                                          ble approach determine gene essential Leishmania donovani, caus- <br />                                                          ative agent visceral leishmaniasis. demonstrate gene knockout drug <br />                                                          targeting approaches loss inhibition CYP51 inhibits L. donovani growth.                                                          results validate CYP51 drug target L. donovani support work develop <br />                                                          CYP51-directed therapies visceral leishmaniasis. <br />  <br />  <br />  <br />  <br />                                                        Introduction <br />                                                        Leishmania vector-borne protozoan parasites. digenetic lifecycle; promasti- <br />                                                        gotes transmitted sandfly vector mammalian host, taken                                                        phagocytic cells differentiate amastigote stage macrophage phagolyso- <br />                                                        sosme. Amastigotes proliferate phagolysosome taken sandfly <br />                                                        subsequent bloodmeal. sandfly gut, amastigotes differentiate                                                        promastigotes, completing parasite lifecycle [1]. <br />                                                            Leishmania parasites cause range disease manifestations: cutaneous leishmaniasis                                                        lesions develop site sandfly bite, mucocutaneous leishmaniasis destruc- <br />                                                        tion mucosal tissues nose, mouth throat, visceral leishmaniasis                                                        parasites disseminate liver, bone marrow spleen. Visceral leishmaniasis                                                        lethal form disease. associated high fever, hepatosplenomegaly pancytope- <br />                                                        nia [1]. infecting species Leishmania major determinant disease manifestation; <br />                                                        parasites Leishmania donovani species complex main causes visceral leish- <br />                                                        maniasis, species, including Leishmania major species complex, cause cutane- <br />                                                        ous manifestations [2,3]. <br />                                                            Leishmania parasites distributed tropical subtropical regions world. <br />                                                        350 million people live endemic areas risk developing disease, 12 mil- <br />                                                        lion people currently infected [4]. Overall, 1.6 million new cases year [5], associat- <br />                                                        ed disease burden 3.3 million DALYs 50,000 deaths year [6], making <br />                                                        leishmaniasis second lethal parasitic infection malaria [5].  treatment <br />                                                        options limited; recent progress development single-dose <br />                                                        amphotericin B therapy India [7], treatment regimen effective East Africa <br />                                                        [8]. drugs require long treatment regimens; toxicity drug resistance sig- <br />                                                        nificant concerns [9]. <br />                                                            Cell membrane sterols regulate membrane fluidity contribute organization                                                        membrane domains. Unlike mammalian cells, similar fungi, Leishmania Trypano- <br />                                                        soma parasite cell membranes contain ergosterol ergosterol-like sterols choles- <br />                                                        terol. Sterols generated acetyl-<span id='am-43' about='obo:IMR_0200354' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-44' property="oboInOwl:id" content="IMR:0200354" datatype="xsd:string"></span><span id='am-45' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-46' property="rdfs:label" content="CoA" datatype="xsd:string"></span><span id='am-47' property="oboInOwl:hasDbXref" content="KEGG:C00010" datatype="xsd:string"></span>CoA</span> multistep metabolic pathway.                                                        steps, catalyzed <span id='am-100' about='obo:IMR_0200410' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-101' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-102' property="rdfs:label" content="Acetoacetyl-CoA" datatype="xsd:string"></span><span id='am-103' property="oboInOwl:hasDbXref" content="KEGG:C00332" datatype="xsd:string"></span><span id='am-104' property="oboInOwl:id" content="IMR:0200410" datatype="xsd:string"></span>acetoacetyl-CoA</span> thiolase, HMG-CoA synthase HMG-CoA reductase, <br />                                                        lead generation mevalonate. Mevalonate substrate isoprenoid pathway <br />                                                        generates <span id='am-12' about='obo:IMR_0200097' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-13' property="oboInOwl:id" content="IMR:0200097" datatype="xsd:string"></span><span id='am-14' property="rdfs:label" content="Farnesyl diphosphate" datatype="xsd:string"></span><span id='am-15' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-16' property="oboInOwl:hasDbXref" content="KEGG:C00448" datatype="xsd:string"></span>farnesyl diphosphate</span>. <span id='am-28' about='obo:IMR_0200481' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-29' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-30' property="oboInOwl:hasDbXref" content="KEGG:C00751" datatype="xsd:string"></span><span id='am-31' property="rdfs:label" content="Squalene" datatype="xsd:string"></span><span id='am-32' property="oboInOwl:id" content="IMR:0200481" datatype="xsd:string"></span>Squalene</span> synthase produces squalene farne- <br />                                                        syl diphosphate molecules. Squalene oxidized squalene oxidase, resulting product <br />                                                        cyclized <span id='am-7' about='obo:IMR_0200096' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-8' property="oboInOwl:hasDbXref" content="KEGG:C01724" datatype="xsd:string"></span><span id='am-9' property="oboInOwl:id" content="IMR:0200096" datatype="xsd:string"></span><span id='am-10' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-11' property="rdfs:label" content="Lanosterol" datatype="xsd:string"></span>lanosterol</span>. Sterol 14alpha-demethylase (CYP51, LdBPK_111100.1) catalyses  <br />  <br />  <br /> PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003588            March 13, 2015                                                        2 / 17 <br />                                                                                                        Essentiality Leishmania donovani CYP51 <br />  <br />  <br />  <br />                                             removal 14alpha-methyl group lanosterol [10,11]. L. infantum CYP51 enzyme <br />                                             broad substrate specificity, ability demethylate obtusifoliol, C4-norlanosterol <br />                                             14&#206;&#177;-methylzymosterol, addition lanosterol, preference                                             substrates [12]. following steps differ ergosterol cholesterol biosynthesis, <br />                                             variations reaction intermediates enzymes involved depending species [13]. <br />                                             key steps ergosterol biosynthesis methylation C24 sterol <br />                                             24-methyltransferase, leading formation fecosterol, episterol 5-dehydroepisterol <br />                                             depending substrate [14]. <br />                                                 Azole antifungals investigated treatment Leishmania infections,                                             large variations efficacy species [15]. experiments azole sensitivity                                             visceral Leishmania species showed efficacy ketoconazole [16] oxiconazole [17]  <br />                                             tracellular amastigotes ketoconazole extracellular promastigotes [18]. Posaconazole <br />                                             [19] ketoconazole [20] effective mouse models visceral leishmaniasis, albeit <br />                                             amphotericin B pentavalent antimonial compounds currently used visceral <br />                                             leishmaniasis treatments. Azoles extensively tested cutaneous Leishmania <br />                                             species  instance [21,22,23,24] early work parasites). Given importance <br />                                             CYP51 drug target severity disease caused L. donovani, investigated                                             essentiality L. donovani CYP51 biological pharmacological methods. <br />  <br />  <br />                                             Materials Methods <br />                                             Ethics statement <br />                                             vertebrate animal studies performed accordance USDA Animal Welfare <br />                                             Act Guide Care Use Laboratory Animals National Institutes                                             Health. protocol approved University California San Francisco Institutional <br />                                             Animal Care Use Committee (protocol AN087316). Euthanasia performed carbon <br />                                             dioxide inhalation followed cervical dislocation. <br />  <br />  <br />                                             Cell culture infection <br />                                             L. donovani 1S/Cl2D promastigotes maintained 26&#194;&#176;C M199 medium (Sigma) sup- <br />                                             plemented 10% heat inactivated fetal bovine serum (FBS, Sigma), 25 mM HEPES, penicil- <br />                                             lin, streptomycin, <span id='am-55' about='obo:IMR_0100126' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001697 obo:IMR_0000001 obo:IMR_0001698'><span id='am-56' property="oboInOwl:hasExactSynonym" content="Adenine riboside" datatype="xsd:string"></span><span id='am-57' property="rdfs:label" content="9-B-D-ribofuranosyl-9H-purin-6-amine" datatype="xsd:string"></span><span id='am-58' property="oboInOwl:hasExactSynonym" content="9-B-D-ribofuranosyl-9H-purin-6-amine" datatype="xsd:string"></span><span id='am-59' property="rdfs:label" content="adenosine" datatype="xsd:string"></span><span id='am-60' property="oboInOwl:id" content="IMR:0100126" datatype="xsd:string"></span><span id='am-61' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-62' property="obo:IAO_0000115" content="A nucleoside that is composed of adenine and d-ribose. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter." datatype="xsd:string"></span><span id='am-63' property="oboInOwl:hasDbXref" content="KEGG:C00212" datatype="xsd:string"></span><span id='am-64' property="oboInOwl:hasAlternativeId" content="IMR:0200246" datatype="xsd:string"></span><span id='am-65' property="oboInOwl:hasExactSynonym" content="Adenosine" datatype="xsd:string"></span><span id='am-66' property="oboInOwl:hasExactSynonym" content="Ribofuranosyladenine" datatype="xsd:string"></span><span id='am-67' property="rdfs:label" content="Ribofuranosyladenine" datatype="xsd:string"></span><span id='am-68' property="rdfs:label" content="Adenine riboside" datatype="xsd:string"></span><span id='am-69' property="rdfs:label" content="Adenosine" datatype="xsd:string"></span>adenosine</span>, glutamine, hemin, <span id='am-38' about='obo:IMR_0200356' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-39' property="oboInOwl:id" content="IMR:0200356" datatype="xsd:string"></span><span id='am-40' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-41' property="rdfs:label" content="Folic acid" datatype="xsd:string"></span><span id='am-42' property="oboInOwl:hasDbXref" content="KEGG:C00504" datatype="xsd:string"></span>folic acid</span> pH 7.2. Axenic amastigote <br />                                             differentiation performed described [25]: promastigotes resuspended amasti- <br />                                             gote media (M199 medium supplemented 25% FBS, streptomycin, penicillin, succinic <br />                                             acid, <span id='am-33' about='obo:IMR_0200350' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-34' property="rdfs:label" content="Adenine" datatype="xsd:string"></span><span id='am-35' property="oboInOwl:hasDbXref" content="KEGG:C00147" datatype="xsd:string"></span><span id='am-36' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-37' property="oboInOwl:id" content="IMR:0200350" datatype="xsd:string"></span>adenine</span>, glycerol, <span id='am-85' about='obo:IMR_0200183' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0001695 obo:IMR_0000001'><span id='am-86' property="oboInOwl:id" content="IMR:0200183" datatype="xsd:string"></span><span id='am-87' property="rdfs:label" content="L-Proline" datatype="xsd:string"></span><span id='am-88' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-89' property="oboInOwl:hasDbXref" content="KEGG:C00148" datatype="xsd:string"></span>L-proline</span> folic acid, pH 5.5) cell density 5x106 cells/mL <br />                                             transferred 37&#194;&#176;C, 5% <span id='am-23' about='obo:IMR_0200324' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-24' property="oboInOwl:id" content="IMR:0200324" datatype="xsd:string"></span><span id='am-25' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-26' property="oboInOwl:hasDbXref" content="KEGG:C00011" datatype="xsd:string"></span><span id='am-27' property="rdfs:label" content="CO2" datatype="xsd:string"></span>CO2</span>. <br />                                                  THP-1 macrophages maintained RMPI 1640 media supplemented 5% FBS 1% <br />                                             penicillin-streptomycin 37&#194;&#176;C, 5% CO2. Leishmania infection, THP-1 cells treated <br />                                             50 ng/mL phorbol 12-myristate 13-acetate (PMA) 48 h infected station- <br />                                             ary phase promastigotes. Cells fixed 4% <span id='am-90' about='obo:IMR_0200017' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-91' property="rdfs:label" content="Formaldehyde" datatype="xsd:string"></span><span id='am-92' property="oboInOwl:id" content="IMR:0200017" datatype="xsd:string"></span><span id='am-93' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-94' property="oboInOwl:hasDbXref" content="KEGG:C00067" datatype="xsd:string"></span>formaldehyde</span> stained                                             40 ,60 -diamidino-2-phenylindole (DAPI). Images obtained automated InCell 2000 <br />                                             automated imaging (G.E. Healthcare) parasite levels determined using CELL <br />                                             developer 1.9 software  S1 Methods), leading determination cell boundaries                                             counting parasite inside boundary outside nucleus automated fashion. <br />                                                  Female BALB/c mice (17&#226;&#8364;&#8220;20 g, 6 group) purchased Simonsen Laboratories <br />                                             maintained animal care facility pathogen-free conditions. Mice infected <br />                                             intravenously tail vein 5x107 stationary phase promastigotes sacrificed 28 days <br />                                             post- infection. Liver parasite burden determined direct counting amastigotes  <br />  <br />  <br /> PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003588   March 13, 2015                                                     3 / 17 <br />                                                                                                        Essentiality Leishmania donovani CYP51 <br />  <br />  <br />  <br />                                             Diff-Quick stained liver impressions calculated Leishman-Donovan Units (LDU): num- <br />                                             ber amastigotes 1000 cell nuclei &#195;&#8212; liver weight (g). <br />  <br />  <br />                                             Generation transfected L. donovani lines <br />                                             sequences retrieved TriTrypDB [26]. 30 L. donovani CYP51 flanking sequences <br />                                             amplified PCR parasite genomic DNA (LdBPK_111100.1, primers 1 2), <br />                                             digested SpeI XbaI, ligated XbaI site vectors pGEM-PAC pGEM- <br />                                             Hyg. 50 CYP51 flanking region amplified primers 3 4, digested SpeI XbaI, <br />                                             ligated SpeI site vectors containing CYP51 30 flanking region. <br />                                             Knockout cassettes liberated restriction enzyme digestion SpeI XbaI.                                             CYP51 coding region amplified PCR genomic DNA (primers 5 6), digested <br />                                             BglII ligated BglII site pXNG4 vector [27]. cases, constructs                                             verified diagnostic digest sequencing. <br />                                                 Transfection performed described [28] electroporation cytomix transfection <br />                                             buffer (120mM KCl, 0,15mM CaCl2, 10mM K2HPO4, 25mM HEPES, 2mM EDTA, 2mM <br />                                             MgCl2) using BioRad Gene Pulser Xcell, delivering pulses 1500 V 25 &#206;&#188;F. Parasites <br />                                             transfected hygromycin knockout cassette; HKO clonal lines selected <br />                                             100 &#206;&#188;g/ml hygromycin (Invitrogen), transfected pXNG4 vector                                             pXNG4 vector encoding CYP51, generating HKO + C HKO + CYP lines, <br />                                             respectively. Double transfectants maintained combination hygromycin 100 <br />                                             &#206;&#188;g/ml nourseothricin (GoldBio). HKO + C HKO + CYP lines transfected pu- <br />                                             romycin knockout cassette clonal HKO + C + PAC HKO + CYP + PAC lines isolated <br />                                             limiting dilution selection hygromycin, nourseothricin 20 &#206;&#188;g/ml puromycin <br />                                             (Sigma). Correct targeting CYP51 genes verified PCR using primers 7  CYP51 <br />                                             50 UTR) 8  hygromycin resistance gene) 9  puromycin resistance gene). Persistence <br />                                             CYP51 genes double resistant, uncomplemented strains loss chromosomal CYP51 <br />                                             complemented strains verified PCR (primers 10 + 11 primers 12 + 13, respec- <br />                                             tively). Primer 12 upstream CYP51, outside knockout cassette, primer 13  <br />                                             neals CYP51 gene. <br />  <br />  <br />                                             Ganciclovir selection <br />                                             50 &#206;&#188;g/mL ganciclovir (Invivogen) added parasite cultures. qPCR extracted DNA <br />                                             monitor pXNG4 loss flow cytometry analysis assess GFP levels performed week- <br />                                             ly  . Results shown represent average independent selection experiments <br />                                             total seven independent clonal lines. <br />  <br />  <br />                                             Quantitative PCR <br />                                             DNA extracted described previously [29]. qPCR reactions containing 100 ng parasite <br />                                             DNA Lightcycler 480 Sybr green Master mix (Roche) run Stratagene Mx3005P <br />                                             RT-PCR thermocycler using following thermal profile: initial denaturation 95&#194;&#176;C                                             10 min, 40 cycles denaturation 95&#194;&#176;C 10 s, annealing 57&#194;&#176;C 20 s extension <br />                                             72&#194;&#176;C 20 s. Melting curve analysis agarose gel electrophoresis used confirm <br />                                             correct PCR product formation. Chromosomal CYP51 (primers 14 15), total CYP51 (prim- <br />                                             ers 16 17), pXNG4 (primers 18 19) relative levels determined qPCR using <br />                                             2-&#206;&#8221;&#206;&#8221;Ct method [30], normalizing serine acetyltransferase (SAT, primers 20 21)                                             cystathionine beta-synthase (CBS, primers 22 23), previously shown present                                             copies L. donovani [31]. <br />  <br />  <br />  <br /> PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003588   March 13, 2015                                                     4 / 17 <br />                                                                                                         Essentiality Leishmania donovani CYP51 <br />  <br />  <br />  <br />                                             Flow cytometry <br />                                             Analyses performed BDFACSDiva LSRII flow cytometer HTS mode. Cells                                             stained 5 &#206;&#188;M propidium iodide (PI, Sigma). Quadrant gates set used PI-stained <br />                                             wild-type parasites (GFP-negative) percentage GFP+ PI- cells determined using FloJo X <br />                                             software (Tree Star . <br />  <br />                                             SDS PAGE Western blot <br />                                             1x107 parasites lysed 1x LDS buffer (Invitrogen) separated using NuPage bis-tris <br />                                             precast polyacrylamide gels (Invitrogen). Proteins transferred PVDF membrane <br />                                             (BioRad). Western blot performed described [32]. Affinity-purified anti-CYP51 anti- <br />                                             bodies (Genescript) anti-GAPDH antibody  Paul Michels, Universit&#195;&#169; catholique                                             Louvain, Bruxelles) used 1:5,000 dilution. secondary antibody 1:5,000 dilu- <br />                                             tion peroxidase-conjugated anti-rabbit IgG antibody (GE Healthcare). proteins vi- <br />                                             sualized using SuperSignal West Pico Chemoluminescent Substrate (Thermo Scientific). <br />                                             Proteins expression levels quantified Image J program, normalizing CYP51 levels                                             GAPDH levels. <br />  <br />                                             Sterol GC-MS <br />                                             Sterol extraction performed described [33]. Briefly, parasite cell pellet resus- <br />                                             pended chloroform-methanol solution (2:1 ratio), dried nitrogen <span id='am-1' about='obo:IMR_0001720' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-2' property="rdfs:label" content="gas" datatype="xsd:string"></span><span id='am-3' property="oboInOwl:hasDbXref" content="MeSH:D005740" datatype="xsd:string"></span><span id='am-4' property="obo:IAO_0000115" content="The vapor state of matter; nonelastic fluids in which the molecules are in free movement and their mean positions far apart. Gases tend to expand indefinitely, to diffuse and mix readily with other gases, to have definite relations of volume, temperature, and pressure, and to condense or liquefy at low temperatures or under sufficient pressure." datatype="xsd:string"></span><span id='am-5' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-6' property="oboInOwl:id" content="IMR:0001720" datatype="xsd:string"></span>gas</span>, followed <br />                                             overnight treatment chloroform. organic phase washed water                                             dried nitrogen. dried pellet resuspended chloroform-methanol (9:1 ratio), <br />                                             washed water. Acetonitrile added samples, washing steps  <br />                                             peated solvents evaporated nitrogen. <br />                                                Extracted sterols derivatized resuspending dried residue 25 &#206;&#188;L hexanes <br />                                             75 &#206;&#188;L BSTFA (Sigma-Aldrich, St. Louis MO) 2 hr 37&#194;&#176;C generate trimethylsilyl <br />                                             (TMS) sterols. TMS-derivatized sterols analyzed using gas chromatography-mass spec- <br />                                             trometry (GC-MS) Agilent HP 6850 GC coupled mass selective detector (Agilent <br />                                             MSD 5973) operating 70 eV electron impact mode. sterols separated using                                             DB5-MS analytical column (30 m x 0.25 mm inner diameter, 0.25-&#206;&#188;m film thickness, Agilent) <br />                                             temperature profile begins 200&#194;&#176;C 1 min, increases 15&#194;&#176;C/min 300&#194;&#176;C, <br />                                             holds 300&#194;&#176;C 20 min. inlet detector temperatures held 200                                             250&#194;&#176;C, respectively. MSD set scan range 50&#226;&#8364;&#8220;750 m sterol profiling. Selected <br />                                             <span id='am-17' about='obo:IMR_0001658' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-18' property="oboInOwl:hasDbXref" content="CHEBI:24870" datatype="xsd:string"></span><span id='am-19' property="rdfs:label" content="ion" datatype="xsd:string"></span><span id='am-20' property="obo:IAO_0000115" content="An atom that has either gained or lost electrons to acquire a chage; for example Na+ and Cl-." datatype="xsd:string"></span><span id='am-21' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-22' property="oboInOwl:id" content="IMR:0001658" datatype="xsd:string"></span>Ion</span> Monitoring (SIM) used ergosterol quantification using GC tempera- <br />                                             ture profile assaying fragment ions specific ergosterol elute time win- <br />                                             dow ergosterol standard: m 468.4, 378.4, 363.4, 337.4, 253.1 prepared 8-point <br />                                             standard curve ergosterol using serial dilution concentration range 9 pmol 1.2 <br />                                             nmoles. area curve SIM assay compared standard samples                                             calculate ergosterol concentrations. <br />  <br />                                             Ergosterol biosynthesis inhibitor assay <br />                                             Amphotericin B, ketoconazole voriconazole purchased Sigma. CYP51 <br />                                             inhibitors synthesized house  supplementary methods [34,35,36]). Stationary <br />                                             phase promastigotes (8x105/mL) treated 72 h fold dilution inhibitors                                             384 plate format. Resazurin (0.025 mg/mL, Santa Cruz) added 5 h, cells fixed, <br />                                             fluorescence measured 490 nm excitation 595 nm emission wavelengths. Data                                             normalized amphotericin B positive control DMSO vehicle negative control  <br />  <br />  <br /> PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003588   March 13, 2015                                                      5 / 17 <br />                                                                                                        Essentiality Leishmania donovani CYP51 <br />  <br />  <br />  <br />                                             plate, EC50 values calculated using Collaborative Drug Discovery Vault software. T. cruzi <br />                                             cell-based activity determined high content screening triplicate, previously  <br />                                             scribed [36]. <br />  <br />  <br />                                             Results <br />                                             Leishmania donovani tolerate modulations CYP51 levels <br />                                             generated half knockout L. donovani parasites (HKO strains) single CYP51 allele <br />                                             replaced puromycin hygromycin resistance marker (Fig. 1A; Fig. 2B                                             knockout approach). CYP51 located chromosome 11, disomic reference <br />                                             L. donovani genomes [37], trisomic clinical L. donovani isolates [31]. addition, <br />                                             Leishmania genome contains direct indirect repeats promote extrachro- <br />                                             mosomal element formation drug pressure essential genes [31,38]. Prior target- <br />                                             ing CYP51 allele, verified CYP51 copy number parasites transfected <br />                                             knockout cassette, resistant hygromycin (HygR HKO strains) puro- <br />                                             mycin (PAC HKO strains). HKO strains contained half CYP51 DNA content                                             wild-type, indicating loss alleles (Fig. 1B). Furthermore, CYP51 protein levels <br />                                             decreased fold half knockout strains. Complementation episomal <br />                                             CYP51 gene restored protein expression levels comparable wild-type L. donovani <br />                                             (Fig. 1C). <br />                                                Given importance ergosterol biosynthesis trypanosomatid parasites, assessed <br />                                             impact loss CYP51 expression proceeding targeting second <br />                                             CYP51 allele. vivo vitro infectivity comparable strains (Fig. 1D, Fig. 1E, <br />                                             S1 Fig); differences wild-type transfected strains changes                                             CYP51 levels infectivity HKO, HKO+C HKO+CYP comparable. strains <br />                                             comparable sterol profiles (Fig. 1F) ergosterol levels (Table 1). <br />  <br />  <br />                                             Essentiality CYP51: Biological approach <br />                                             L. donovani parasites able tolerate fold reductions CYP51 protein lev- <br />                                             els apparent effects parasite phenotype, proceeded targeting second <br />                                             CYP51 allele.  obtained correct targeting CYP51 hygromycin pu- <br />                                             romycin resistance markers, double drug-resistant parasites retained CYP51, despite multi- <br />                                             ple targeting attempts (Fig. 2A). used facilitated knockout approach (Fig. 2B) <br />                                             [27,39,40], targeting second CYP51 allele presence episomal CYP51 complementa- <br />                                             tion. control, targeted second allele parasites transfected pXNG4 <br />                                             vector [27] (S2 Fig.). obtained complete loss chromosomal CYP51 genes pres- <br />                                             ence episomal CYP51; genomic CYP51 retained parasites transfected                                             plasmid, supporting essentiality CYP51 (Fig. 2C). <br />                                                 pXNG4 vector used complementation encodes green fluorescence protein <br />                                             gene (GFP) herpes virus <span id='am-105' about='obo:IMR_0200384' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-106' property="oboInOwl:id" content="IMR:0200384" datatype="xsd:string"></span><span id='am-107' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-108' property="oboInOwl:hasDbXref" content="KEGG:C00214" datatype="xsd:string"></span><span id='am-109' property="rdfs:label" content="Thymidine" datatype="xsd:string"></span>thymidine</span> kinase gene; cells contain plasmid sensi- <br />                                             tive treatment ganciclovir (GCV). performed negative selection                                             pXNG4 vector treating transfected parasites GCV. Plasmid persistence                                             GCV treatment monitored qPCR flow cytometry GFP. pXNG4 plasmid <br />                                             lost faster parasites transfected vector (retain chromosomal <br />                                             CYP51) parasites transfected vector encoding CYP51  source                                             CYP51), indicating selection CYP51 persistence (Fig. 2D, 2E). clonal line (HKO1 + <br />                                             CYP + PAC2) showed greater loss pXNG4 plasmid, retained CYP51 DNA levels <br />                                             comparable half knockout strains, 2^(-&#206;&#8221;&#206;&#8221;Ct) values 0.6, leading ergosterol levels <br />  <br />  <br />  <br /> PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003588   March 13, 2015                                                     6 / 17 <br />                                                                                                                 Essentiality Leishmania donovani CYP51 <br />  <br />  <br />  <br />  <br /> Fig 1. Modulation CYP51 levels L. donovani.  Replacement CYP51 allele homologous recombination. Correct targeting knockout <br /> cassettes verified PCR using primer knockout cassette upstream CYP51 (primers 7 8 (hygromycin), 7 9 <br /> (puromycin), . B, qPCR quantification chromosomal CYP51 levels, normalized SAT CBS wild-type levels. C, CYP51 protein levels half knockout complemented strains. CYP51 GAPDH detected Western blot   quantified densitometry   D, vitro <br /> infectivity half knockout complemented strains. THP1 macrophages infected 10:1 parasite macrophage ratio. Cells fixed stained <br />  <br />  <br />  <br />  <br /> PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003588      March 13, 2015                                                              7 / 17 <br />                                                                                                                Essentiality Leishmania donovani CYP51 <br />  <br />  <br />  DAPI 24, 48 72 h post-infection, macrophage infection levels determined automated high-throughput imaging parasite detection. E, vivo infectivity half knockout complemented strains. BALB/c mice infected intravenously. Liver parasite burden (Leishman-Donovan Units, <br /> LDU) determined 28 days post-infection counting stained liver impressions. F, Sterol profiling GC-MS. <br /> doi:10.1371/journal.pntd.0003588.g001 <br />  <br />                                               similar wild-type, 7 weeks GCV selection (S4 Fig). Overall, results support <br />                                               essentiality CYP51 L. donovani. <br />  <br />                                               Essentiality CYP51: Pharmacological approach <br />                                               persistence CYP51-encoding pXNG4 plasmids GCV negative selection indi- <br />                                               cates CYP51 essential L. donovani. Pharmacological inhibition CYP51                                               lead parasite growth arrest death. 4-aminopyridyl-based compound series <br />                                               CYP51 inhibitors derived initial hit target-based high-throughput screening, <br />                                               followed hit lead optimization using structure-activity relationships (SAR), structure- <br />                                               property relationships (SPR), biological structural evaluation T. cruzi CYP51 <br />                                               [34,35,36,41,42,43,44]. tested 205 compounds series wild-type intracellular L. <br />                                               donovani amastigotes high content assay. Fifty compounds 60% activity                                               10 &#206;&#188;M used dose-response experiments wild-type L. donovani promastigotes <br />                                               strains modulated CYP51 expression (HKO, HKO+C HKO+CYP). Rep- <br />                                               resentative compounds highest activity promastigotes shown Fig. 3, Fig. 4. <br />                                               Activity intracellular amastigotes shown S3 Table. clear difference EC50 values <br />                                               observed strains ketoconazole voriconazole controls, possibly                                               lower activity L. donovani. house compounds potent assay                                               commercial antifungal azoles. Overall, HKO+CYP strains sensitive 4- <br />                                               aminopyridyl-based inhibitors compared HKO+C, indicating compounds inhibit <br />                                               Leishmania growth CYP51-mediated mechanism. confirms targeting CYP51 <br />                                               pharmacologically promotes inhibition parasite growth, supporting essentiality                                               CYP51 L. donovani metabolism. <br />  <br />                                               Discussion <br />                                               CYP51 (sterol 14alpha-demethylase) belongs large cytochrome P450 enzyme family, <br />                                               contains 20,000 members. significant variation sequence level, <br />                                               CYP51 highly conserved eukaroytes structural level [45].  small varia- <br />                                               tions species strains lead significant variations sensitivity CYP51  <br />                                               hibitors.  single <span id='am-48' about='obo:IMR_0001695' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-49' property="rdfs:label" content="amino acid" datatype="xsd:string"></span><span id='am-50' property="oboInOwl:id" content="IMR:0001695" datatype="xsd:string"></span><span id='am-51' property="oboInOwl:hasDbXref" content="MeSH:D000596" datatype="xsd:string"></span><span id='am-52' property="obo:IAO_0000115" content="Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins." datatype="xsd:string"></span><span id='am-53' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-54' property="oboInOwl:hasDbXref" content="CHEBI:33709" datatype="xsd:string"></span>amino acid</span> change CYP51 T. cruzi Y strain compared                                               Tulahuen strain associated significant decrease sensitivity CYP51 inhibitors, <br />                                               concentrations caused 100% inhibition Tulahuen enzyme [46]. <br />                                                   vitro side comparison azole efficacy promastigotes Leishmania <br />                                               species provides conflicting results: studies observed increased susceptibility different <br />                                               L. donovani strains ketoconazole itraconazole compared different L. major strains <br />                                               [14,18], studies different L. donovani L. major strains indicated L. <br />                                               donovani resistant ketoconazole [47] posaconazole [19] L. major. sepa- <br />                                               rate study, intracellular L. donovani amastigotes sensitive ketoconazole                                               amastigotes cutaneous leishmaniasis patients [16]. L. major promastigotes  <br />                                               sensitive 4-aminopyridyl-based compound series CYP51 inhibitors, lon- <br />                                               ger exposure compounds (S2 Table). regards clinical trials, azoles shown <br />                                               large variations clinical efficacy Leishmania species, effect 90% <br />                                               efficacy [15], majority studies focused cutaneous leishmaniasis. <br />                                               single case report successful posaconazole use treat cutaneous <br />  <br />  <br />  <br /> PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003588     March 13, 2015                                                             8 / 17 <br />                                                                                                                  Essentiality Leishmania donovani CYP51 <br />  <br />  <br />  <br />  <br /> Fig 2. Essentiality CYP51 L. donovani.  Persistence CYP51 gene correct targeting knockout cassettes CYP51 locus. <br /> Correct targeting knockout cassettes verified PCR using primer knockout cassette upstream CYP51 (primers 7 8 <br /> (hygromycin) 7 9 (puromycin)). CYP51 amplified primers coding region (primers 10 11). B, Targeting strategy. Primers 7 8 7 9 expected PCR product sizes confirm correct targeting chromosomal CYP51 alleles indicated arrows (step 4). C, Loss chromosomal CYP51 presence episomal CYP51 complementation strains complemented vector. PCR performed <br />  <br />  <br />  <br />  <br /> PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003588       March 13, 2015                                                              9 / 17 <br />                                                                                                                     Essentiality Leishmania donovani CYP51 <br />  <br />  <br />  <br /> using primers 12+13. D, pXNG4 loss monitored qPCR GCV selection absence positive negative selection (untreated samples). <br /> pXNG4 Ct values normalized SAT levels samples positive selection (treated nourseothricn (NTC) absence GCV). E, GFP <br /> positive, propidium iodide (PI) negative levels monitored flow cytometry. Percentage GFP+ PI- cells normalized levels week 1. *, <br /> p&lt;0.05 compared HKO+CYP+PAC. <br /> doi:10.1371/journal.pntd.0003588.g002 <br />  <br />                                                leishmaniasis caused L. donovani infantum [48], knowledge clinical <br />                                                trial azoles visceral leishmaniasis. Persistent Leishmania growth presence azoles <br />                                                tied tolerance 14-methyl sterol accumulation parasite membranes [14,18,49] <br />                                                increased exogenous cholesterol incorporation [18]. <br />                                                    Recent work indicated CYP51 appears dispensable L. major, albeit high fit- <br />                                                ness cost [14]. contrast, given (1) inability fully knockout chromosomal CYP51 unless <br />                                                provide extrachromosomal episomal source CYP51, (2) persistence CYP51 <br />                                                episome negative selection conditions source CYP51, <br />                                                (3) CYP51-specific growth inhibition 4-aminopyridyl-based non-azole CYP51  <br />                                                hibitors L. donovani, results support essentiality CYP51 L. donovani. extra- <br />                                                chromosomal episomal-encoded CYP51 fully complement knockout phenotype, <br />                                                active, given ability substitute chromosomal CYP51 increase  <br />                                                sistance 4-aminopyridyl-based non-azole CYP51 inhibitors directly target                                                CYP51 active site [13,34,36]. <br />                                                    L. donovani L. major CYP51 overall similar. Comparing L. major L. <br />                                                donovani CYP51 protein sequences highlights amino acid substitutions &#206;&#178; helices 1&#226;&#8364;&#8220;1 <br />                                                1&#226;&#8364;&#8220;2 single amino acid insertion C-terminal L. donovani compared                                                L. major (S5 Fig). suggests mechanisms responsible observed dif- <br />                                                ferences CYP51 essentiality L. major L. donovani.  squalene synthase, <br />                                                catalyzes committed step ergosterol biosynthesis, involved resis- <br />                                                tance itraconazole [50]; differences sensitivity squalene synthase inhibitors                                                observed L. major L. donovani [51]. Likewise, differences sensitivity <br />                                                sterol 24-methyltransferase inhibitors L. major L. donovani [52]. Finally,                                                activity L. donovani 3-hydroxy-3-methylglutaryl coenzyme reductase (HMG-CoA reduc- <br />                                                tase) 50-fold higher activity L. major enzyme [53]. HMG-CoA reductase <br />  <br />  <br />                                                Table 1. Ergosterol levels half knockout strains. <br />  <br />                                                Stage                                              Strain                          Ergosterol levels (pmol                                                Promastigotes                                      Wild-type                       7236.7 <br />                                                                                                   HKO                             5167.3 <br />                                                                                                   HKO + C                         7535.2 <br />                                                                                                   HKO + CYP                       5887.9 <br />                                                Axenic amastigotes                                 Wild-type                       1374.7 <br />                                                                                                   HKO                             1102.8 <br />                                                                                                   HKO + C                          904.4 <br />                                                                                                   HKO + CYP                        983.3 <br />                                                Intracellular amastigotes                          Wild-type                        135.2 <br />                                                                                                   HKO                              165.3 <br />                                                                                                   HKO + C                          462.0 <br />                                                                                                   HKO + CYP                        327.7 <br />                                                                                                   Normalized host cholesterol levels intracellular amastigotes <br />  <br />                                                doi:10.1371/journal.pntd.0003588.t001 <br />  <br />  <br />  <br />  <br /> PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003588           March 13, 2015                                                         10 / 17 <br />                                                                                                          Essentiality Leishmania donovani CYP51 <br />  <br />  <br />  <br />  <br /> Fig 3. Susceptibility half knockout strains CYP51 inhibitors (EC50, &#206;&#188;M): compounds significant differences HKO + C HKO + CYP strains. Values &#194;&#177; standard error shown. p-values comparison HKO+C HKO+CYP. <br /> doi:10.1371/journal.pntd.0003588.g003 <br />  <br />                                             catalyzes step sterol synthesis <span id='am-95' about='obo:IMR_0200414' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-96' property="rdfs:label" content="Acetyl-CoA" datatype="xsd:string"></span><span id='am-97' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-98' property="oboInOwl:hasDbXref" content="KEGG:C00024" datatype="xsd:string"></span><span id='am-99' property="oboInOwl:id" content="IMR:0200414" datatype="xsd:string"></span>acetyl-CoA</span> rate-limiting step                                             human sterol biosynthesis [54]. Finally, member cytochrome P450 family, <br />                                             CYP5122A1 (LdBPK_270090.1), modulates ergosterol levels L. donovani [55]; ex- <br />                                             pression activity altered CYP51-deficient L. major, complement loss                                             CYP51. <br />                                                differences CYP51 sterol biosynthetic pathways L. major                                             L. donovani, additional factors contribute observed difference CYP51 <br />  <br />  <br />  <br />  <br /> PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003588   March 13, 2015                                                      11 / 17 <br />                                                                                                          Essentiality Leishmania donovani CYP51 <br />  <br />  <br />  <br />  <br /> Fig 4. Susceptibility half knockout strains CYP51 inhibitors (EC50, &#206;&#188;M): compounds decreased activity HKO + CYP strains. Values &#194;&#177; <br /> standard error shown. p-values comparison HKO+C HKO+CYP. <br /> doi:10.1371/journal.pntd.0003588.g004 <br />  <br />  <br />  <br />                                             essentiality.  Xu et al showed L. major CYP51 involved protection heat <br />                                             shock [14]. L. major considerably sensitive heat shock L. donovani,                                             mechanism resistance heat shock differs species, L. donovani-spe- <br />                                             cific A2 protein family key contributor L. donovani survival heat stress [25,32]. <br />                                             Likewise, gp63 lipophosphoglycan levels altered CYP51-deficient L. major [14]. <br />                                             Lipophosphoglycan structurally different L. major L. donovani [56], gp63 <br />                                             members L. donovani species complex active L. major gp63 [57]. <br />  <br />  <br />  <br />  <br /> PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003588   March 13, 2015                                                      12 / 17 <br />                                                                                                         Essentiality Leishmania donovani CYP51 <br />  <br />  <br />  <br />                                                Overall, results support investigation CYP51 inhibitors treatment vis- <br />                                             ceral leishmaniasis. recent clinical trial results using posaconazole treatment                                             Chagas disease disappointing [58], enhanced potency observed L. donovani 4- <br />                                             aminopyridyl-based non-azole inhibitors CYP51 compared ketoconazole voriconazole <br />                                             supports development novel inhibitor scaffolds, potentially using 4-aminopyridyl  <br />                                             hibitor series starting point. Given lower efficacy inhibitors Leishmania com- <br />                                             pared T. cruzi, efforts medicinal chemistry optimize                                             pharmacodynamic pharmacokimetic properties compounds activity                                             Leishmania. particular, efficacy lower intracellular wild-type L. donovani amas- <br />                                             tigotes compared transfected promastigote strains (S3 Table), possibly additional <br />                                             constraints regards drug uptake host cell parasite-containing acidic <br />                                             phagolysosome. Finally, work work indicate CYP51-targeted therapies <br />                                             suitable treat Leishmania species. highlights importance considering <br />                                             variations species strains early drug development process. <br />  <br />  <br />                                             Supporting Information <br />                                             S1 Methods. Supplemental methods. <br />                                             (DOC) <br />                                             S1 Scheme. Synthesis CYP51 inhibitors. Reagents conditions:   Arylboronic acid, <br />                                             5 mol% Pd2(dba)3, 10 mol% PCy3, 2M K3PO4, dioxane, 100&#194;&#176;C (microwave), 1h, ca. 90% (b) <br />                                             1-(aryl)piperazine, Pd(OAc)2, P(o-tolyl)3, Cs2CO3, toluene, 50&#194;&#176;C, 48 h, ca. 70% (c) 10% NaOH <br />                                             (aq), MeOH/THF (1/1), 60&#194;&#176;C, 3 h, ca. 95% (d) 11, 12, 13, 14, 15, 16, 17, 18b, 19b, 20b                                              appropriate), PyBOP, HOBt, Et3N, CH2Cl2, 23&#194;&#176;C, 1h, ca. 50%. <br />                                             (PPT) <br />                                             S1 Fig. vitro infectivity half knockout complemented strains. THP1 macrophages <br />                                             infected 10:1 parasite macrophage ratio. Cells fixed stained DAPI <br />                                             24, 48 72 h post-infection, parasite numbers infected cell determined auto- <br />                                             mated high-throughput imaging parasite detection <br />                                             (PPT) <br />                                             S2 Fig. Targeting hygromycin puromycin resistance knockout cassettes. Correct tar- <br />                                             geting hygromycin   puromycin (B) resistance knockout cassettes verified                                             PCR using primer upstream CYP51 specific resistance marker (primers 7 <br />                                             8 (hygromycin) 7 9 (puromycin)). HKO1 + CYP + PAC clones 2, 4, 5; HKO2 + C + <br />                                             PAC clones 1, 2 3; HKO2 + CYP + PAC clones 1, 2, 4 5 correct targeting                                             knockout cassettes. <br />                                             (PPT) <br />                                             S3 Fig. Representative flow cytometry analysis weeks GCV selection. Parasites <br />                                             treated NTC (positive selection), GCV (negative selection) left untreated (-NTC- <br />                                             GCV) weeks. representative cell line shown HKO + C + PAC HKO + <br />                                             CYP + PAC.  Quadrant analysis. Numbers indicate percentage cells quadrant. <br />                                             B, Representative GFP histogram plots PI-negative cells. Wild-type parasites (dotted line) <br />                                             serve non-fluorescent cutoff reference. Black, NTC treatment (positive selection). Grey, <br />                                             GCV treatment (negative selection). <br />                                             (PPT) <br />                                             S4 Fig. Persistence CYP51 HKO1 + CYP + PAC2 strain. CYP51 persistence  <br />                                             sessed qPCR   Western blot (B) following seven weeks GCV selection. Sterol <br />  <br />  <br />  <br /> PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003588   March 13, 2015                                                     13 / 17 <br />                                                                                                               Essentiality Leishmania donovani CYP51 <br />  <br />  <br />  <br />                                             profiles ergosterol levels determined GC-MS (C). Chol., cholesterol. <br />                                             Erg, ergosterol. <br />                                             (PPT) <br />                                             S5 Fig. Alignment L. major L. donovani CYP51.  Clustal Omega alignment. &#206;&#178; 1&#226;&#8364;&#8220;1 <br />                                             1&#226;&#8364;&#8220;2 helices positioned [12]. B, Secondary structure alignment. 3-D models L. <br />                                             major L. donovani CYP51 generated using TASSER server. scoring <br />                                             models overlaid using UCSF Chimera. Red, L. donovani. Blue, L. major. <br />                                             (PPT) <br />                                             S1 Table. Oligonucleotides used study. <br />                                             (XLS) <br />                                             S2 Table. Susceptibility L. major CYP51 inhibitors (EC50, &#206;&#188;M). <br />                                             (DOC) <br />                                             S3 Table. Susceptibility intracellular L. donovani amastigotes select CYP51 inhibitors. <br />                                             (DOC) <br />  <br /> </body></html>